Stamaril

Stamaril

vaccine, yellow fever

Manufacturer:

sanofi pasteur

Distributor:

DKSH
Concise Prescribing Info
Contents
Live attenuated yellow fever virus (17D-204 strain)
Indications/Uses
Active immunization against yellow fever in persons travelling to, passing through or living in an endemic area; travelling to any country that requires an International Certificate of Vaccination for entry; handling potentially infectious materials (eg, laboratory personnel).
Dosage/Direction for Use
Primary vaccination Adult & childn ≥9 mth 0.5 mL as a single SC dose at least 10 days before exposure. Elderly Adult dose. Re-vaccination 0.5 mL as a single SC dose. May be needed in patients who had an insufficient immune response after their primary vaccination. Duration: At least 10 yr & may be life-long.
Contraindications
Hypersensitivity to eggs, chicken proteins. Severe hypersensitivity reactions (eg, anaphylaxis) after a previous dose of any yellow fever vaccine. Congenital or idiopathic immunosuppression; history of thymus dysfunction including myasthenia gravis, thymoma, thymectomy. Symptomatic or asymptomatic HIV infection. Moderate or severe febrile or acute illness. Infant <6 mth.
Special Precautions
Do not inject intravascularly. Do not give by IM route to persons w/ bleeding disorder (eg, haemophilia or thrombocytopenia) or on anticoagulant therapy. Yellow fever vaccine-associated neurotropic disease. Do not administer to immunosuppressed patients & those w/ symptomatic or asymptomatic HIV infection. Delay vaccination until at least 1 mth after completing the course in patients who received systemic corticosteroids for ≥14 days. False positive results w/ laboratory test for other flavivirus diseases (eg, dengue or Japanese encephalitis). Do not use during pregnancy & lactation. Childn born to HIV positive mothers. Not recommended in childn 6-9 mth. Elderly ≥60 yr.
Adverse Reactions
Appetite loss; drowsiness, cephalalgia; vomiting; myalgia; irritability, crying, fever, asthenia, inj site pain/tenderness. Nausea; rash; arthralgia; inj site erythema/redness, haematoma, induration, oedema/swelling.
Drug Interactions
Do not mix w/ other vaccine or medicinal product. Immunosuppressants (eg, cytotoxic agents, systemic steroids).
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BL01 - yellow fever, live attenuated ; Belongs to the class of yellow fever viral vaccines.
Presentation/Packing
Form
Stamaril vaccine inj
Packing/Price
(vial + syringe containing diluent) 1 dose x 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in